These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 360299)

  • 41. Role of the vascular endothelium.
    Hoak JC; Parks WM; Fry GL; Brotherton AA; Czervionke RL
    Prog Clin Biol Res; 1982; 89():281-94. PubMed ID: 6180442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The stimulatory effect of prostacyclin (PGI2) on isolated rabbit and rat aorta is probably associated to the generation of a thromboxane A2 (TXA2) "like-material".
    Borda ES; Sterin-Borda L; Gimeno MF; Lazzari MA; Gimeno AL
    Arch Int Pharmacodyn Ther; 1983 Jan; 261(1):79-89. PubMed ID: 6342559
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of oral aspirin dose on platelet aggregation and vascular prostacyclin (PGI2) synthesis in humans and rabbits.
    Ellis EF; Wright KF; Jones PS; Richardson DW; Ellis CK
    J Cardiovasc Pharmacol; 1980; 2(4):387-97. PubMed ID: 6156337
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rabbit arterial endothelium and subendothelium. A change in interfacial free energy that may promote initial platelet adhesion.
    Boyce JF; Wong PC; Schürch S; Roach MR
    Circ Res; 1983 Sep; 53(3):372-7. PubMed ID: 6192943
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The influence of red blood cells on the effects of aspirin or sulphinpyrazone on platelet adherence to damaged rabbit aorta.
    Davies JA; Essien E; Cazenave JP; Kinlough-Rathbone RL; Gent M; Mustard JF
    Br J Haematol; 1979 Jun; 42(2):283-91. PubMed ID: 465372
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of PGI2 (prostacyclin) synthesis in the arterial wall enhances the formation of white platelet thrombi in vivo.
    Bourgain RH
    Haemostasis; 1978; 7(4):252-5. PubMed ID: 95991
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
    Hawiger J; Parkinson S; Timmons S
    Nature; 1980 Jan; 283(5743):195-7. PubMed ID: 6985716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of prostacyclin (PGI2) on immune-complex-induced neutropenia.
    Camussi G; Bussolino F; Tetta C; Caligaris Cappio F; Coda R; Macchiorlatti E; Alberton M; Roffinello C; Segoloni G
    Immunology; 1983 Apr; 48(4):625-33. PubMed ID: 6339375
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in man.
    Hassan S; Pickles H; Fish A; Burke C; Warrington S; O'Grady J
    Br J Clin Pharmacol; 1982 Sep; 14(3):369-77. PubMed ID: 6127095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of acetylsalicylic acid, sulfinpyrazone and dipyridamole on platelet adhesion and aggregation in flowing native and anticoagulated blood.
    Baumgartner HR
    Haemostasis; 1979; 8(3-5):340-52. PubMed ID: 511014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epoprostenol inhibits human platelet-leukocyte mixed conjugate and platelet microparticle formation in whole blood.
    Tamburrelli C; Crescente M; Izzi B; Barisciano M; Donati MB; de Gaetano G; Cerletti C
    Thromb Res; 2011 Nov; 128(5):446-51. PubMed ID: 21624644
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
    Beretz A; Stierle A; Anton R; Cazenave JP
    Biochem Pharmacol; 1982 Nov; 31(22):3597-600. PubMed ID: 6295405
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Model system to study interaction of platelets with damaged arterial wall. I. Inhibition of platelet adhesion to subendothelium by aspirin and dipyridamole.
    Silver MJ; Ingerman-Wojenski CM; Sedar AW; Smith M
    Exp Mol Pathol; 1984 Aug; 41(1):141-52. PubMed ID: 6468632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. De-aggregatory action of prostacyclin in vivo and its enhancement by theophylline.
    Gryglewski RJ; Korbut R; Ocetkiewicz A
    Prostaglandins; 1978 Apr; 15(4):637-44. PubMed ID: 353903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of aspirin inhibition of PGI2 production on platelet adherence to normal and damaged rabbit aortae.
    Dejana E; Cazenave JP; Groves HM; Kinlough-Rathbone RL; Richardson M; Packham MA; Mustard JF
    Thromb Res; 1980 Feb 1-15; 17(3-4):453-64. PubMed ID: 6989013
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of PGI2 on platelet aggregation and adenylate cyclase activity in human type IIa hypercholesterolemia.
    Colli S; Lombroso M; Maderna P; Tremoli E; Nicosia S
    Biochem Pharmacol; 1983 Jul; 32(13):1989-93. PubMed ID: 6347202
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human platelet reactivity with intact segments of rabbit aorta and selected regions of rabbit, rat and human aorta.
    McGill M; Conter E; Bosmann HB
    Thromb Res; 1985 Jun; 38(6):635-40. PubMed ID: 4024048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stimulation of renin release by 6-oxo-prostaglandin E1 and prostacyclin.
    McGiff JC; Spokas EG; Wong PY
    Br J Pharmacol; 1982 Jan; 75(1):137-44. PubMed ID: 7042021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of prostacyclin on tumor cell-induced platelet aggregation.
    Menter DG; Onoda JM; Taylor JD; Honn KV
    Cancer Res; 1984 Feb; 44(2):450-6. PubMed ID: 6362850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.